Adventist Healthcare Fort Washington Medical Center INC
Adventist Healthcare Fort Washington Medical Center INC was paid $8.63M by Medicaid between Jan 2018 and Nov 2024, across 85 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 27% of everything it billed.
FT WASHINGTON, MD 20744
Next to other Psychiatry Physician providers in Maryland
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,244 | $2.04M | |
| 2019 | 22,984 | $1.61M | |
| 2020 | 14,502 | $939K | |
| 2021 | 18,630 | $1.40M | |
| 2022 | 13,245 | $1.24M | |
| 2023 | 9,265 | $747K | |
| 2024incomplete | 6,362 | $649K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 27% | 18,541 | 15,815 | $2.37M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 5,884 | 5,170 | $1.23M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 6,113 | 5,354 | $905K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.1% | 3,870 | 3,421 | $524K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.0% | 1,682 | 1,469 | $517K |
| 80053 | Comprehensive metabolic panel | 2.6% | 6,442 | 5,484 | $222K |
| 84484 | 2.3% | 3,705 | 2,970 | $202K | |
| G0378 | Hospital observation service, per hour | 2.3% | 424 | 350 | $198K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 10,580 | 8,877 | $193K |
| 84702 | 1.9% | 3,157 | 2,648 | $167K | |
| 87490 | 1.7% | 960 | 884 | $146K | |
| 71045 | Radiologic examination, chest; single view | 1.7% | 3,733 | 3,244 | $144K |
73 more codes
| 87590 | 1.6% | 952 | $134K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.2% | 1,009 | $106K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 3,993 | $105K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 1,486 | $105K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.0% | 547 | $90K |
| 76830 | Ultrasound, transvaginal | 1.0% | 283 | $90K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.0% | 955 | $88K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,360 | $83K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 780 | $80K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 737 | $76K |
| 87905 | <1% | 793 | $73K | |
| 83690 | <1% | 3,280 | $66K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,086 | $66K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 248 | $63K |
| 0223U | <1% | 153 | $57K | |
| 87581 | <1% | 525 | $52K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 972 | $46K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 809 | $42K |
| 82962 | <1% | 1,494 | $37K | |
| 81015 | <1% | 2,231 | $34K | |
| 87276 | <1% | 451 | $26K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,234 | $26K |
| 81002 | <1% | 1,479 | $24K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 63 | $23K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,412 | $17K |
| 83518 | <1% | 437 | $15K | |
| 87081 | <1% | 184 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 85 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 85 | $12K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 60 | $12K |
| 85378 | <1% | 312 | $12K | |
| 73562 | <1% | 186 | $11K | |
| 81001 | <1% | 875 | $11K | |
| 83880 | <1% | 229 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,097 | $9K |
| 90715 | <1% | 76 | $8K | |
| 83735 | <1% | 566 | $8K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 82 | $7K |
| 73630 | <1% | 120 | $7K | |
| 83605 | <1% | 125 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,946 | $5K |
| 81003 | <1% | 398 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 58 | $5K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 668 | $4K |
| 85610 | <1% | 146 | $4K | |
| 93971 | <1% | 12 | $3K | |
| 81025 | <1% | 120 | $3K | |
| 86803 | <1% | 63 | $3K | |
| 85730 | <1% | 97 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 275 | $2K |
| 84703 | <1% | 83 | $2K | |
| 73610 | <1% | 29 | $2K | |
| 73130 | <1% | 36 | $2K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 646 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 348 | $2K |
| 73110 | <1% | 16 | $1K | |
| 73030 | <1% | 39 | $1K | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 695 | $986.28 |
| 86901 | <1% | 43 | $748.62 | |
| 87220 | <1% | 15 | $606.10 | |
| 94799 | <1% | 12 | $602.38 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 12 | $458.13 |
| 80320 | <1% | 12 | $414.19 | |
| 87210 | <1% | 16 | $355.20 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 536 | $334.65 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 121 | $262.91 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 292 | $187.65 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 17 | $36.69 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 23 | $34.13 |
| 0637 | 0% | 42 | $0.00 | |
| 0250 | 0% | 223 | $0.00 | |
| 0270 | 0% | 239 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Holmes Regional Medical Center, INC. | Melbourne, FL | $12.33M |
| Holmes Regional Medical Center, INC | Palm Bay, FL | $7.24M |
| Hospice of Health First INC. | West Melbourne, FL | $4.13M |
| Cape Canaveral Hospital, INC. | Cocoa Beach, FL | $3.66M |
| Viera Hospital INC | Melbourne, FL | $2.04M |
| Blackwell Physicians, LLC | Rockville, MD | $1.94M |
| Adventist Physician Services, INC. | Rockville, MD | $405K |
| Adventist Physician Services, INC. | Takoma Park, MD | $79K |
| Holmes Regional Medical Center, INC. | Melbourne, FL | $25K |
| Adventist Physician Services, INC. | Germantown, MD | $5K |
| Doctors Gi Partnership LTD | Palm Bay, FL | $932.71 |
| Cape Canaveral Hospital, INC. | Melbourne, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.